A Simple ICT-Based Fluorescent Probe for HOCl and Bioimaging Applications
Biosensors · 18.07.2023 · 13 (7) · 744
DOI: 10.3390/bios13070744 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors, online erschienen am 18.07.2023. Verfasst von Yan Zheng und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Harbin University of Commerce, Harbin 150076, China. Hauptthemen laut MEDLINE: Fluorescent Dyes, Chemical and Drug Induced Liver Injury, Chronic. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Research and Development Guidance Project of Heilongjiang Province, Heilongjiang Natural Science Foundation Joint Guidance Project, Key Research and Development Project of Heilongjiang Province.
Abstract (Originalsprache)
Over the past few decades, drug-induced liver damage (DILI) has become a serious public health problem due to drug abuse. Among multifarious reactive oxygen species, mounting evidence attests that ClO− has been used as a potential biomarker in DILI. In this work, a new “turn-on” fluorescent probe 1 was designed and synthesized by modifying 4′-hydroxybiphenyl-4-carbonitrile (dye 2) with N, N-dimethylthiocarbamate as a response site for detecting ClO−. Probe 1 displayed a low detection limit (72 nM), fast response time (30 s), wide pH operating range (6–8), great tissue penetration, large Stokes shift (125 nm) and 291-fold fluorescence enhancement at 475 nm in the mapping of ClO−. Probe 1 could trace amounts of exogenous and endogenous ClO− with high sensitivity in MCF-7 cells and HeLa cells. Expectantly, the fluoxetine-induced liver injury model is successfully established, and probe 1 has been used for detecting the fluctuation of ClO− levels in the mouse model of fluoxetine-induced liver injury. All in all, probe 1 with its high specificity, good biological compatibility and liver tissue penetration ability is expected to assist with the early diagnosis of DILI and the clinical screening of various new drugs. We expect that probe 1 could be efficiently used as a powerful molecular tool to predict clinical DILI and explore molecular mechanisms between molecules and disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Harbin University of Commerce, Harbin 150076, China.
- Engineering Research Center on Natural Antineoplastic Drugs, Ministry of Education, Harbin University of Commerce, Harbin 150076, China.
Förderung
- Key Research and Development Guidance Project of Heilongjiang Province
- Heilongjiang Natural Science Foundation Joint Guidance Project
- Key Research and Development Project of Heilongjiang Province
- Harbin University of Commerce Youth Innovation Talent Support Program
- Industrialization project support plan of Harbin University of Commerce
Zitieren
APA
Zheng, Y., Wu, S., Bing, Y., Li, H., Liu, X., Li, W., Zou, X., & Qu, Z. (2023). A Simple ICT-Based Fluorescent Probe for HOCl and Bioimaging Applications. Biosensors, 13(7), 744. https://doi.org/10.3390/bios13070744
Vancouver
Zheng Y, Wu S, Bing Y, Li H, Liu X, Li W, et al. A Simple ICT-Based Fluorescent Probe for HOCl and Bioimaging Applications. Biosensors. 2023;13(7):744. doi:10.3390/bios13070744
BibTeX
@article{Zheng2023,
author = {Zheng, Yan and Wu, Shuang and Bing, Yifan and Li, Huimin and Liu, Xueqin and Li, Wenlan and Zou, Xiang and Qu, Zhongyuan},
title = {A Simple ICT-Based Fluorescent Probe for HOCl and Bioimaging Applications},
journal = {Biosensors},
year = {2023},
volume = {13},
number = {7},
pages = {744},
doi = {10.3390/bios13070744}
}
EUVIMED